Update of the 2009 started comprehensive European market assessment for molecular diagnostics from the end user perspective. Hospital and private laboratories have been surveyed to collect information on NA tests, test volumes, used platforms and technologies (amplification & detection) and reagents. For data reliability and accurate projections at segment level a 3 step methodology has been applied:Step 1: Identification of the total number of laboratoriesStep 2: Identification of the total number of laboratories using NA technologies (several units per hospital)Step 3: Interviews with NA laboratories on NA test volume, kits, platforms and trends. A list of 38 NA tests has been provided to the labs for structured data entry. The report covers key platforms of molecular diagnostics, including Polymerase Chain Reaction (PCR), Real Time PCR (RT-PCR), TMA, LCR, NASBA, SDA, HCA, bDNA.

Please note - You may purchase the 2009 version of this report at 50% discount, if purchased together with the 2011 data. Please contact our customer services team for more information

Executive Summary

dii is an international market research company entirely specialised in healthcare markets providing market information and support to strategic business decisions. In cooperation with key industry we have desigend the Continuous European Molecular Market Assessment which has been realized in 2009 and 2011 with the 2 main objectives:1) Assess the market for molecular diagnostics (# of labs using which technology, test volumes, platforms and reagents)2) Understand long term trends and needs